Evidence map›Paper›PMID 25072206›Full record

ReviewAnnals of the American Thoracic Society2014

Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota.

Perry S Brown, Christopher E Pope, Robyn L Marsh, Xuan Qin, Sharon McNamara, Ronald Gibson, Jane L Burns, Gail Deutsch, Lucas R Hoffman

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in Annals of the American Thoracic Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  4. Review
  5. Article
  6. Journal of medical microbiology · 2022
    Article
  7. Commensal Bacteria in the Cystic Fibrosis Airway Microbiome ReduceFrontiers in cellular and infection microbiology · 2022
    Article
  8. Review
  9. Microorganisms · 2021
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2019
    Article
  16. Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  17. BAL Fluid Metaproteome in Acute Respiratory Failure.American journal of respiratory cell and molecular biology · 2018
    Article
  18. Review
  19. Article
  20. Microbial diversity within the airway microbiome in chronic pediatric lung diseases.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Perry S Brown1 Department of Pediatrics, St. Luke's Regional Medical Center, Boise, Idaho.
Christopher E Pope
Robyn L Marsh
Xuan Qin
Sharon McNamara
Ronald Gibson
Jane L Burns
Gail Deutsch
Lucas R Hoffman
Pediatrics and Genetics · USMenzies School of Health Research · AUSt. Luke’s Boise Medical Center · USUniversity of Washington · US

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss · 2010 to 2026
$21.4M
Pseudomonas Aeruginosa Early CF Adaptive Changes: A Translational StudyK02HL105543 · NHLBI · UNIVERSITY OF WASHINGTON · PI HOFFMAN, LUCAS R · 2011 to 2014
$400k
NHLBI NIH HHS K02 HL105543NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

rationaleThe airways of people with cystic fibrosis (CF) are chronically infected with a variety of bacterial species. Although routine culture methods are usually used to diagnose these infections, culture-independent, DNA-based methods have identified many bacterial species in CF respiratory secretions that are not routinely cultured. Many prior culture-independent studies focused either on microbiota in explanted CF lungs, reflecting end-stage disease, or those in oropharyngeal swabs, which likely sample areas in addition to the lower airways. Therefore, it was unknown whether the lower airways of children with CF, well before end-stage but with symptomatic lung disease, truly contained diverse microbiota.

objectivesTo define the microbiota in the diseased lung tissue of a child who underwent lobectomy for severe, localized CF lung disease.

methodsAfter pathologic examination verified that this child's lung tissue reflected CF lung disease, we used bacterial ribosomal RNA gene pyrosequencing and computational phylogenetic analysis to identify the microbiota in serial sections of the tissue. MEASUREMENTS AND MAIN

resultsThis analysis identified diverse, and anatomically heterogeneous, bacterial populations in the lung tissue that contained both culturable and nonculturable species, including abundant Haemophilus, Ralstonia, and Propionibacterium species. Routine clinical cultures identified only Staphylococcus aureus, which represented only a small fraction of the microbiota found by sequencing. Microbiota analysis of an intraoperative oropharyngeal swab identified predominantly Streptococcus species. The oropharyngeal findings therefore represented the lung tissue microbiota poorly, in agreement with findings from earlier studies of oropharyngeal swabs in end-stage disease.

conclusionsThese results support the concept that diverse and spatially heterogeneous microbiota, not necessarily dominated by "traditional CF pathogens," are present in the airways of young, symptomatic children with early CF lung disease.

Indexed as

MicrobiotaBronchitisBronchoalveolar Lavage FluidChild, PreschoolCystic FibrosisDNA, BacterialFollow-Up StudiesHumansLungPneumonectomyRadiography, ThoracicRisk AssessmentSeverity of Illness IndexTissue Culture TechniquesTomography, X-Ray ComputedTreatment OutcomeDNA, Bacterialcystic fibrosisinfectionlobectomymicrobiota

Identifiers

PMID25072206
PMCPMC4214062
OpenAlexW2170668239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.